Status:
COMPLETED
Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Osteogenesis Imperfecta
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
Osteogenesis imperfecta (OI) is a rare genetic disorder of increased bone fragility and low bone mass. It is conceivable that children and adolescents with OI are less active than healthy peers becaus...
Eligibility Criteria
Inclusion
- Child with osteogenesis imperfecta
- Child followed in the Reference centre for constitutional bone diseases in the Hôpital Femme Mère Enfant
- Parent (s) / legal guardian who has been informed of the study and has accepted participation in the study by signing the consent.
- Patient benefiting from a social security scheme
Exclusion
- Medical and surgical contraindications to adapted physical activity.
Key Trial Info
Start Date :
November 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 14 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04119388
Start Date
November 4 2019
End Date
October 14 2022
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant
Bron, France, 69500